Caitong Securities(SH:601108) Xin Lang Cai Jing·2025-11-05 06:49Group 1 - The core viewpoint of the news is that Yinosh Biotechnology Co., Ltd. has seen a stock price increase of 5.09%, reaching 45.40 CNY per share, with a total market capitalization of 6.4 billion CNY as of November 5 [1] - Yinosh specializes in providing non-clinical research services in the biopharmaceutical sector, with 96.31% of its revenue coming from non-clinical services, 3.42% from clinical services, and 0.27% from other sources [1] - The company is located in the China (Shanghai) Free Trade Pilot Zone and was established on May 12, 2010, with its listing date set for September 3, 2024 [1] Group 2 - From the perspective of fund holdings, one fund under Caitong Securities Asset Management has a significant position in Yinosh, holding 65,400 shares, which accounts for 8.49% of the fund's net value, ranking it as the eighth-largest holding [2] - The Caitong Asset Management Innovative Pharmaceutical Mixed A fund has achieved a year-to-date return of 50.59%, ranking 843 out of 8,150 in its category, and a one-year return of 47.86%, ranking 867 out of 8,043 [2] - The fund manager, Yi Xiaojin, has been in the position for 7 years and 182 days, with the fund's total asset size at 359 million CNY and a best return of 47.11% during his tenure [2]